
Psoriasis Global Market Report 2022
Description
Psoriasis Global Market Report 2022
Psoriasis Global Market Report 2022 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global psoriasis drugs market as it emerges from the Covid 19 shut down.
Reasons to Purchase
Where is the largest and fastest growing market for the psoriasis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Psoriasis Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered: 1) By Drug class: Interleukin Inhibitors; Corticosteroids; Anti-Inflammatory; Tumor Necrosis Factor Inhibitor
2) By Distribution Channel: Hospitals; Retail Pharmacies; E-Commerce
3) By Drug Types: Small molecules; Biologics
4) By Route Of Administration: Oral; Tropical; Injectable
5) By Disease Indication: Plaque Psoriasis; Nail Psoriasis; Guttate Psoriasis; Pustular Psoriasis; Erythrodermic Psoriasis
Companies Mentioned: AbbVie Inc.; Pfizer Inc.; Novartis; Eli Lilly and Company; Celgene Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Psoriasis Global Market Report 2022 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global psoriasis drugs market as it emerges from the Covid 19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Where is the largest and fastest growing market for the psoriasis drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Psoriasis Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The Market Characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
- Market segmentations break down market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
- Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered: 1) By Drug class: Interleukin Inhibitors; Corticosteroids; Anti-Inflammatory; Tumor Necrosis Factor Inhibitor
2) By Distribution Channel: Hospitals; Retail Pharmacies; E-Commerce
3) By Drug Types: Small molecules; Biologics
4) By Route Of Administration: Oral; Tropical; Injectable
5) By Disease Indication: Plaque Psoriasis; Nail Psoriasis; Guttate Psoriasis; Pustular Psoriasis; Erythrodermic Psoriasis
Companies Mentioned: AbbVie Inc.; Pfizer Inc.; Novartis; Eli Lilly and Company; Celgene Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
175 Pages
- 1. Executive Summary
- 2. Psoriasis Drugs Market Characteristics
- 3. Psoriasis Drugs Market Trends And Strategies
- 4. Impact Of COVID-19 On Psoriasis Drugs
- 5. Psoriasis Drugs Market Size And Growth
- 5.1. Global Psoriasis Drugs Historic Market, 2016-2021, $ Billion
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints On The Market
- 5.2. Global Psoriasis Drugs Forecast Market, 2021-2026F, 2031F, $ Billion
- 5.2.1. Drivers Of The Market
- 5.2.2. Restraints On the Market
- 6. Psoriasis Drugs Market Segmentation
- 6.1. Global Psoriasis Drugs Market, Segmentation By Drug class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Interleukin Inhibitors
- Corticosteroids
- Anti-Inflammatory
- Tumor Necrosis Factor Inhibitor
- 6.2. Global Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Hospitals
- Retail Pharmacies
- E-Commerce
- 6.3. Global Psoriasis Drugs Market, Segmentation By Drug Types, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Small molecules
- Biologics 4
- 6.4. Global Psoriasis Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Oral
- Tropical
- Injectable
- 6.5. Global Psoriasis Drugs Market, Segmentation By Disease Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- Plaque Psoriasis
- Nail Psoriasis
- Guttate Psoriasis
- Pustular Psoriasis
- Erythrodermic Psoriasis
- 7. Psoriasis Drugs Market Regional And Country Analysis
- 7.1. Global Psoriasis Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 7.2. Global Psoriasis Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 8. Asia-Pacific Psoriasis Drugs Market
- 8.1. Asia-Pacific Psoriasis Drugs Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 8.3. Asia-Pacific Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 9. China Psoriasis Drugs Market
- 9.1. China Psoriasis Drugs Market Overview
- 9.2. China Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
- 9.3. China Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
- 10. India Psoriasis Drugs Market
- 10.1. India Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 10.2. India Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 11. Japan Psoriasis Drugs Market
- 11.1. Japan Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 11.2. Japan Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 12. Australia Psoriasis Drugs Market
- 12.1. Australia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 12.2. Australia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 13. Indonesia Psoriasis Drugs Market
- 13.1. Indonesia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 13.2. Indonesia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 14. South Korea Psoriasis Drugs Market
- 14.1. South Korea Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 14.2. South Korea Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 15. Western Europe Psoriasis Drugs Market
- 15.1. Western Europe Psoriasis Drugs Market Overview
- 15.2. Western Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 15.3. Western Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 16. UK Psoriasis Drugs Market
- 16.1. UK Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 16.2. UK Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 17. Germany Psoriasis Drugs Market
- 17.1. Germany Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 17.2. Germany Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 18. France Psoriasis Drugs Market
- 18.4. France Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 18.5. France Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 19. Eastern Europe Psoriasis Drugs Market
- 19.1. Eastern Europe Psoriasis Drugs Market Overview
- 19.2. Eastern Europe Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 19.3. Eastern Europe Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 20. Russia Psoriasis Drugs Market
- 20.1. Russia Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 20.2. Russia Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 21. North America Psoriasis Drugs Market
- 21.1. North America Psoriasis Drugs Market Overview
- 21.2. North America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 21.3. North America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 22. USA Psoriasis Drugs Market
- 22.1. USA Psoriasis Drugs Market Overview
- 22.2. USA Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 22.3. USA Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 23. South America Psoriasis Drugs Market
- 23.1. South America Psoriasis Drugs Market Overview
- 23.2. South America Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 23.3. South America Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 24. Brazil Psoriasis Drugs Market
- 24.1. Brazil Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 24.2. Brazil Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 25. Middle East Psoriasis Drugs Market
- 25.1. Middle East Psoriasis Drugs Market Overview
- 25.2. Middle East Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 25.3. Middle East Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 26. Africa Psoriasis Drugs Market
- 26.1. Africa Psoriasis Drugs Market Overview
- 26.2. Africa Psoriasis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 26.3. Africa Psoriasis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
- 27. Psoriasis Drugs Market Competitive Landscape And Company Profiles
- 27.1. Psoriasis Drugs Market Competitive Landscape
- 27.2. Psoriasis Drugs Market Company Profiles
- 27.2.1. AbbVie Inc.
- 27.2.1.1. Overview
- 27.2.1.2. Products and Services
- 27.2.1.3. Strategy
- 27.2.1.4. Financial Performance
- 27.2.2. Pfizer Inc.
- 27.2.2.1. Overview
- 27.2.2.2. Products and Services
- 27.2.2.3. Strategy
- 27.2.2.4. Financial Performance
- 27.2.3. Novartis
- 27.2.3.1. Overview
- 27.2.3.2. Products and Services
- 27.2.3.3. Strategy
- 27.2.3.4. Financial Performance
- 27.2.4. Eli Lilly and Company.
- 27.2.4.1. Overview
- 27.2.4.2. Products and Services
- 27.2.4.3. Strategy
- 27.2.4.4. Financial Performance
- 27.2.5. Celgene Corporation
- 27.2.5.1. Overview
- 27.2.5.2. Products and Services
- 27.2.5.3. Strategy
- 27.2.5.4. Financial Performance
- 28. Psoriasis Drugs Pipeline Analysis
- 29. Key Mergers And Acquisitions In The Psoriasis Drugs Market
- 30. Psoriasis Drugs Market Future Outlook and Potential Analysis
- 31. Appendix
- 31.1. Abbreviations
- 31.2. Currencies
- 31.3. Research Inquiries
- 31.4. The Business Research Company
- 31.5. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.